Thus, our study revealed an essential role and clinical significance of circSLC38A1 in BC via activating the transcription of TGF-beta2 in an ILF3-dependent manner, extending the understanding of the importance of circRNA-mediated transcriptional regulation in BC metastasis.
Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-beta2 signaling axis.